Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu
Enjoy your FREE PREVIEW which shows only 2024 data and 25 documents. Contact Patent Forecast for full access.        

AI Biotech/Diagnostics: Cardio

Read More News and Insights

Boehringer Ingelheim Betting on AI

AI Biotech/Diagnostics: Cardio Patent Forecast®

May 7, 2020

This week, global pharmaceutical manufacturer Boehringer Ingelheim announced a collaboration with BERG. BERG is a clinical-stage biology company which utilizes AI to map diseases and revolutionize treatments across neurology, rare diseases, and cancer. BERG identifies clinical biomarkers to accelerate the discovery and development pathway.

The goal for this collaboration is to better understand the spectrum of inflammatory diseases and their biological drivers. BERG is also not new to collaborating with pharmaceutical companies. The company brings with it extensive IP in the AI biotech sector, focusing mostly on molecular diagnostic tools. One of their most recent granted patents teaches a Bayesian network model for healthcare diagnostics. 

Last month, Boehringer Ingelheim announced a partnership with Insilico Medicine, also for AI-based drug development. Unlike BERG, Insilico Medicine's focus is on areas including heart failure, cystic fibrosis, and muscular dystrophy. 
 


Relevant Patent Documents

Patent US10482385  

Article Source Link

Endpoints News


Read more like this in News This Week!   or   Share this link with your connections!



301